Triera Biosciences is working to accelerate innovation in the biomanufacturing and life sciences industry worldwide. Triera is a Canadian biosciences company that is developing an aptamer therapeutics platform in partnership with McMaster University.
Aptamers are synthetic single-stranded DNA- or RNA-type molecules that are built from the same building blocks of human DNA or RNA. They can selectively bind to a target with high affinity and specificity, making them ideally suited for detection and treatment applications
Triera is owned by Zentek Ltd., a publicly traded nanotechnology development and commercialization company based out of Canada.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Guelph , Ca
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://triera.ca/
- Keywords
- Aptamer Research.
- HQ
- Guelph
Triera Biosciences Questions
Triera Biosciences's website is https://triera.ca/
Triera Biosciences's LinkedIn profile is https://ca.linkedin.com/company/trierabiosciences
Triera Biosciences has
5 employees.
View email and phone details for 5
employees at Triera Biosciences.
Triera Biosciences's industry is
Pharmaceutical Manufacturing
Triera Biosciences's top competitors are
Nextgreatbigideas,
Alimera,
Titan Mining,
Zentek Nanotech India Pvt. Ltd.,
Nubiyota,
Novelty Nobility Inc.,
Zenteck Ltd,
Zentek Ltd.,
Cytophage Technologies Ltd.,
Ch1 Consulting.
Triera Biosciences's categories are Pharmaceutical Manufacturing
Triera Biosciences's founding year is 2023
